Charles Lombard, MD
Anatomic Pathology & Clinical Pathology · Stanford, CANPI 1720164775
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.5%), speaking fees and ownership interests — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Broncus Medical at 29.7% of the total. Reporting peaked in 2019 at $755 and has fallen 97.2% since, to $21 in 2023.
Across 21 payments — averaging $40.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Broncus Medical$250
- Boston Scientific$216
- Novartis$130
- Merck$79
- Takeda Pharmaceuticals U.S.A., Inc.$51
- Blueprint Medicines Corporation$25
- plus $89 from 5 others
What the payments were for
- Speaking & faculty fees$25030%
- Food & beverage$37445%
- Ownership interest$21626%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Broncus Medical | 1 | $250 |
| Boston Scientific | 1 | $216 |
| Novartis | 7 | $130 |
| Merck | 4 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Blueprint Medicines Corporation | 1 | $25 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Bristol Myers Squibb | 1 | $18 |
| AstraZeneca | 1 | $17 |
| Bayer | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$840 in reported general payments places this provider in the 80th percentile of 814 anatomic pathology & clinical pathology providers in California.
See all anatomic pathology & clinical pathology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in Stanford
- Hua ShanStanford$295K
- Teri LongacreStanford$60K
- Gerald BerryStanford$49K
- Yasodha NatkunamStanford$38K
- Eric YangStanford$34K
- Brooke HowittStanford$31K
- Sucheta SrivastavaStanford$28K
- Siddhartha JaiswalStanford$26K
- Serge AlexanianLos Angeles$3.2M
- Brian ConeLos Angeles$519K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.